InvestorsHub Logo
Followers 14
Posts 1813
Boards Moderated 0
Alias Born 06/15/2011

Re: None

Saturday, 04/18/2020 11:43:20 AM

Saturday, April 18, 2020 11:43:20 AM

Post# of 3683
After posting my last post, time to get to business. I feel with recent events starting months ago with the hire of CFO Ivor Macleod the tide was going to turn for ATHX. Then months later with the hiring of Maia Hansen, the wheels started turning. They would not quit highly successful jobs and come to ATHX if they didn't know what the future held. The two trials for ARDS (400 people) and Trauma (150) people really speaks for itself. The FDA doesn't approve trials if there wasn't something there. The share offering while dilutive I think is a good thing, ATHX needs money and $50 million is a good amount. Trials cost money. Now the next thing we would like to see is BARDA funding this would be the icing on the cake. All IMO